Arbutus Biopharma (ABUS) Other Accumulated Expenses (2013 - 2015)

Arbutus Biopharma (ABUS) has reported Other Accumulated Expenses for 3 consecutive years, with $745000.0 the latest figure, recorded in Q2 2015.

• Quarterly Other Accumulated Expenses rose 169.93% year-over-year to $745000.0 in Q2 2015, while the trailing twelve-month figure through Jun 2015 was $745000.0 (up 169.93% YoY) and the FY2014 annual result came in at $226000.0, down 71.57% from the prior year.
• Other Accumulated Expenses retreated to $745000.0 in Q2 2015 per ABUS's latest filing, from $1.3 million in the prior quarter.
• Over the last five years, Other Accumulated Expenses for ABUS reached as high as $1.3 million in Q1 2015 and fell as low as $226000.0 in Q4 2014.
• A 3-year average of $603000.0 and a median of $510000.0 in 2014 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2014 — Other Accumulated Expenses tumbled 71.57% — and 2015, when it soared 169.93%.
• Year by year, Other Accumulated Expenses stood at $795000.0 in 2013, then slumped by 71.57% to $226000.0 in 2014, then soared by 229.65% to $745000.0 in 2015.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $745000.0, $1.3 million, and $226000.0 for Q2 2015, Q1 2015, and Q4 2014 respectively.